GRHL2 upregulation predicts a poor prognosis and promotes the resistance of serous ovarian cancer to cisplatin

Y Nie, Y Ding, M Yang - OncoTargets and therapy, 2020 - Taylor & Francis
Background GRHL2 has been shown to function in ovarian carcinogenesis. However, the
relationship between GRHL2 and cisplatin (DDP) resistance in serous ovarian cancer (SOC) …

KHDRBS3 promotes paclitaxel resistance and induces glycolysis through modulated MIR17HG/CLDN6 signaling in epithelial ovarian cancer

X Wu, L Qiu, H Feng, H Zhang, H Yu, Y Du, H Wu… - Life Sciences, 2022 - Elsevier
Paclitaxel (PTX) resistance contributes to mortality in epithelial ovarian cancer (EOC).
Aerobic glycolysis is elevated in the tumor environment and may influence resistance to PTX …

Exploration of the Correlation Between GRHL1 Expression and Tumor Microenvironment in Endometrial Cancer and Immunotherapy

S Guo, W Bai, F Cui, X Chen, X Fang… - Pharmacogenomics …, 2024 - Taylor & Francis
Introduction GRHL1 belongs to the family of Grainyhead-like (GRHL). Previous studies have
shown that dysregulation of growth and survival pathways is associated with the GRHL …

Inhibition of GRP78 expression reverses cisplatin resistance in human ovarian cancer

LM Fan, J Su, H Dong, M Wei, MH Cui - Zhonghua yi xue za zhi, 2013 - europepmc.org
Objective To explore the effects of GRP78 suppression on the sensitivity to cisplatin and
elucidate the role and mechanism of GRP78 in ovarian cancer cisplatin resistance. Methods …

Dysregulation of lnc-SNHG1 and miR-216b-5p correlate with chemoresistance and indicate poor prognosis of serous epithelial ovarian cancer

ML Pei, ZX Zhao, T Shuang - Journal of Ovarian Research, 2020 - Springer
Aim This study aimed to explore whether the dysregulation of lnc-small nucleolar RNA host
gene 1 (SNHG1) and miR-216b-5p correlated with chemoresistance and indicated poor …

[HTML][HTML] Experimental and clinical evidence suggests that GRPEL2 plays an oncogenic role in HCC development

MC Lai, QQ Zhu, J Xu, WJ Zhang - American journal of cancer …, 2021 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) continues to cause severe burden worldwide. The limited
options especially toward HCC with metastasis prompts us to identify novel molecules for …

Suppression of the grainyhead transcription factor 2 gene (GRHL2) inhibits the proliferation, migration, invasion and mediates cell cycle arrest of ovarian cancer cells

A Faddaoui, R Sheta, M Bachvarova, M Plante… - Cell Cycle, 2017 - Taylor & Francis
Previously, we have identified the Grainyhead transcription factor 2 gene (GRHL2) as
notably hypomethylated in high-grade (HG) serous epithelial ovarian tumors, compared with …

Inhibition of HDAC1 and DNMT1 modulate RGS10 expression and decrease ovarian cancer chemoresistance

E Cacan, MW Ali, NH Boyd, SB Hooks, SF Greer - PloS one, 2014 - journals.plos.org
RGS10 is an important regulator of cell survival and chemoresistance in ovarian cancer. We
recently showed that RGS10 transcript expression is suppressed during acquired …

Knockdown of GRHL2 inhibited proliferation and induced apoptosis of colorectal cancer by suppressing the PI3K/Akt pathway

F Hu, Z He, C Sun, D Rong - Gene, 2019 - Elsevier
Abstract Grainyhead-like 2 (GRHL2) transcription factor is implicated in many types of
cancers. However, the role of GRHL2 in colorectal cancer (CRC) has not been fully …

Co-overexpression of GRK5/ACTC1 correlates with the clinical parameters and poor prognosis of epithelial ovarian cancer

L Liu, J Lv, Z Lin, Y Ning, J Li, P Liu… - Frontiers in Molecular …, 2022 - frontiersin.org
Background: The prognosis of epithelial ovarian cancer (EOC) is poor, and the present
prognostic predictors of EOC are neither sensitive nor specific. Objective: The aim of this …